This symposium will address some of the challenges in pediatric cystic fibrosis care. Information on improving the diagnosis of CF and newborn screening process will be presented focusing on improvements in the timeliness and accuracy of the initial diagnosis following a positive newborn screen result. Updates on CFTR related metabolic syndrome will be presented including improvements in diagnosis of CF compared to CRMS through educational initiatives as well as potential clinical differences in these patient populations. Lastly, two presentations will be focused on the identification and treatment of pulmonary exacerbations within young children including challenges in diagnosis as well as research updates and future directions.
Describe accurately the diagnosis of CF and CRMS in infants identified through a positive newborn screening.
Review current research and challenges in the identification of pulmonary exacerbations in young children with CF.
Describe the FEV1 Indicated Exacerbation Signal, a new metric which could be used to evaluate pulmonary exacerbation status in children.
Assistant Professor of Pediatrics,
Vanderbilt University Medical Center